Lipstick Angels, a non-profit that brings volunteer makeup artists into hospitals to treat them with facials, makeovers and massage treatments has started a program at NewYork-Presbyterian. Read more
An innovative clinical trial at Weill Cornell Medicine has helped Ralph Hills recover from an aggressive leukemia - without ever being admitted to the hospital. Read more
Findings from a highly anticipated, randomized, phase II trial could possibly pave the path for the FDA approval of the first targeted therapy for patients with triple-negative breast cancer (TNBC), explains Linda T. Vahdat, M.D. Read more
A team led by Doug Fearon, M.D., has traced cachexia to a molecular reprogramming of the liver induced by tumors, which also releases stress hormones that can prevent the immune system from responding. Read more
The metabolic state of patients influences their cancer risk, progression and response to treatment, warns researchers in the lab of Meyer director Lewis Cantley. Read more
Two awards from the Department of Defense will help advance research into metastasis promoting protein Bcl-xL and immune response inhibiting adenosine. Read more
Professor Emeritus Ralph Nachman, M.D., has won a 2016 Mentor Award from the American Society of Hematology for his commitment to training and mentoring early-career hematologists. Read more
A study by Jim Hu, M.D., and colleagues has found that the rate of prostate biopsies and radical prostatectomies decreased following a 2012 United States Preventative Task Force recommendation against prostate specific antigen (PSA) testing. Read more
Olivier Elemento, Ph.D., and Mark Rubin, M.D., penned a guest piece in Oncology Times about genomics in oncology and the role of precision medicine Read more